Delivery Order SPE2DB22D3501-SPE2DB24FUN05
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $86,448.95 and covers the delivery of Sunitinib Malate 25 mg capsules. It is a Firm Fixed Price Delivery Order contract that runs through February 11, 2025. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order from the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sunitinib Malate 25 mg capsules. The order, valued at $37,567.48, has a firm fixed price pricing type and an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by...
- This federal contract award is for the delivery of Sunitinib Malate 37.5 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $20,926.41, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 6, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $14,317.67 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Sunitinib Malate 25 mg capsules with a completion date of January 16, 2026. This is an unset-aside, competitively awarded contract with performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $56,004.64 from the Defense Logistics Agency (DLA). The contract provides for the delivery of Everolimus 5 mg tablets to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of pharmaceutical products, including the medication Sorafenib 200 mg tablet, to the Defense Logistics Agency (DLA). The $94,816.33 delivery order contract has a firm fixed price pricing type and an ultimate completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,020.84 for the pharmaceutical product MYORISAN 40 MG CAPSULE 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,591.02 for the supply of Sirolimus 1 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,511.56 for the supply of Sandostatin LAR Depot 20 mg kits. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,919.39 for the supply of Sandostatin LAR Depot 30 mg kits. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUN05Delivery Order
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,721.43 for the supply of 4563606317 - Sunitinib Malate 50 MG Capsule. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through February 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 2/8/24 |